Brimer Nicole, Lyons Charles, Vande Pol Scott B
Department of Pathology, University of Virginia. P.O. Box 800904, Charlottesville, VA 22908, USA.
Virology. 2007 Feb 20;358(2):303-10. doi: 10.1016/j.virol.2006.08.038. Epub 2006 Oct 4.
The cellular E3 ubiquitin ligase E6AP (UBE3A) interacts with the cancer-associated HPV E6 oncoproteins, where together with the viral E6 oncoprotein it binds and targets the degradation of the p53 tumor suppressor. We find that the HPV-11E6 protein also associates with E6AP in vivo, and thereby can target the degradation of an E6-associated protein. Mutation of an E6-binding LXXLL peptide motif on E6AP eliminated the association, revealing a common mode of interaction between high- and low-risk E6 proteins and E6AP. E6AP was required for the in vivo degradation of DLG1 by both HVP-18 E6 and a chimeric HPV-11E6. The common functional interaction of both cancer-associated and non-cancer-associated E6 proteins with E6AP establishes a common mechanism for E6 proteins trophic to mucosal squamous epithelium.
细胞E3泛素连接酶E6AP(UBE3A)与癌症相关的人乳头瘤病毒(HPV)E6癌蛋白相互作用,它与病毒E6癌蛋白一起结合并靶向降解p53肿瘤抑制因子。我们发现HPV - 11 E6蛋白在体内也与E6AP相关联,因此可以靶向降解一种E6相关蛋白。E6AP上E6结合LXXLL肽基序的突变消除了这种关联,揭示了高危和低危E6蛋白与E6AP之间的共同相互作用模式。E6AP是HPV - 18 E6和嵌合HPV - 11 E6在体内降解DLG1所必需的。癌症相关和非癌症相关E6蛋白与E6AP的共同功能相互作用为对粘膜鳞状上皮有营养作用的E6蛋白建立了一种共同机制。